Nutex Health (NUTX) Short term Debt (2015 - 2026)

Nutex Health's Short term Debt history runs 12 years deep, the most recent figure standing at $16.7 million for Q1 2026.

• In Q1 2026, Short term Debt rose 22.68% year-over-year to $16.7 million; the TTM figure through Mar 2026 stood at $16.7 million (up 22.68% YoY), while the FY2025 annual figure was $13.3 million, down 7.36% from the prior year.
• Short term Debt came in at $16.7 million for Q1 2026 at Nutex Health, up from $13.3 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $31.4 million in Q3 2022 to a low of $2.7 million in Q1 2023.
• A 5-year average of $9.9 million and a median of $7.9 million in 2025 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt jumped 17311.83% in 2022 and sank 89.27% in 2023, its largest moves.
• Nutex Health's Short term Debt stood at $12.5 million in 2022, then dropped by 13.85% to $10.8 million in 2023, then jumped by 33.18% to $14.4 million in 2024, then declined by 7.36% to $13.3 million in 2025, then increased by 25.43% to $16.7 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $16.7 million, $13.3 million, and $5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison